PMC and Research Funder Policies

PubMed Central (PMC) was established in 2000 as the National Library of Medicine’s (NLM) full-text repository of life sciences journal literature. Since 2005, PMC has been the designated repository for papers submitted in accordance with the NIH Public Access Policy. Today, PMC is the full-text repository for papers that fall under the public and open access policies of a number of research funding organizations that support biomedical and life science research. NLM has also partnered with U.S. Federal agencies that fund research in other scientific disciplines to provide a cost-effective government solution for their public access policies.

These partnerships support NLM’s mission of enabling biomedical research; supporting health care and public health; and promoting healthy behavior through the acquisition, organization, and preservation of the world's scholarly biomedical literature. Additionally, these efforts support and catalyze NLM’s commitment to open science policies and practices. In bringing together the research outputs of many funding organizations and scientific disciplines in a central archive, NLM seeks to improve discovery of, provide consistent access to, and ensure long-term preservation of the scientific record.

NLM will consider partnering with funding organizations to leverage the PMC repository infrastructure when the following conditions are met:

• The funder has an established process, e.g., peer review, for selecting projects to fund.
• The funder has a public or open access policy that requires the deposit of funded research papers in PMC. (Funders that do not plan to require PMC deposit should see Other Arrangements.)
• The funder is able to demonstrate how partnering with PMC will further the NLM and NIH missions as well as their own.
• There is evidence that the funder’s policy and implementation will contribute a sufficient volume of papers to PMC on a continuing basis.

To become a partner, a funder must sign a partnership agreement with NLM outlining the responsibilities of the NLM and the partner organization or make arrangements with an existing NLM partner (i.e., Europe PMC, HRA Open). In general, partners may leverage the PMC infrastructure but remain responsible for the maintenance and enforcement of their individual policies.

NLM may also consider extending manuscript submission and repository support to other NIH initiatives that have specific public access requirements. General inquiries about PMC and research funder policies can be sent to pubmedcentral@ncbi.nlm.nih.gov.

Partner Organizations

The following U.S government agencies and private funders have partnerships with NLM to leverage the PMC infrastructure. For specific information on how to comply with the policies of these funders, please see their websites. (The overview of How Papers Get Into PMC may also be of interest.) Any questions about an organization’s policy and requirements should be directed to the funder.

U.S. Federal Agency Partners

• U.S. Department of Health and Human Services
  • National Institutes of Health (NIH)
  • Administration for Community Living (ACL)
  • Agency for Healthcare Research and Quality (AHRQ)
  • Centers for Disease Control and Prevention (CDC)
  • Food and Drug Administration (FDA)
  • Administration for Strategic Preparedness & Response (ASPR)
• Environmental Protection Agency (EPA)
• National Institute of Standards and Technology (NIST)
• U.S. Department of Homeland Security (DHS)
• U.S. Department of Veterans Affairs (VA)

Private and International Partners

• Bill and Melinda Gates Foundation
• Europe PMC Funder Group (see Europe PMC for list)
• Health Research Alliance
  • Alzheimer's Association
  • American Heart Association-American Stroke Association
  • American Society of Neuroradiology (ASNR)
  • Arthritis Foundation
  • The Association for Frontotemporal Degeneration (AFTD)
  • Autism Science Foundation
  • Autism Speaks
  • Breakthrough T1D
  • Cancer Research Institute
  • Crohn's & Colitis Foundation (CCF)
  • CURE, Citizens United for Research in Epilepsy
  • Damon Runyon Cancer Research Foundation
  • Donaghue Foundation
  • Doris Duke Charitable Foundation
  • Foundation Fighting Blindness
  • Foundation for Physical Therapy Research
  • The Gerber Foundation
  • Iridian Genomes (IRGEN)
  • Leukemia and Lymphoma Society
  • LUNGevity Foundation
  • Lymphoma Research Foundation
  • Melanoma Research Alliance
  • National Psoriasis Foundation
  • Pancreatic Cancer Action Network
  • Parkinson's Disease Foundation
  • Patient-Centered Outcomes Research Institute (PCORI)
  • PKD Foundation
  • Susan G. Komen
  • St. Baldrick's Foundation
  • Templeton World Charity Foundation
  • Tuberous Sclerosis Alliance
  • V Foundation for Cancer Research
• Howard Hughes Medical Institute (HHMI)

Other Arrangements

Based on past arrangements with certain national research organizations, PMC will also accept submissions under a PMC selective deposit agreement when one of the following funders is clearly indicated in the metadata deposited with the article:

• Canadian Institutes of Health Research (CIHR)
• HAL-Inserm
• National Aeronautics and Space Administration (NASA)
• Natural Sciences and Engineering Research Council of Canada (NSERC)
• Social Sciences and Humanities Research Council of Canada (SSHRC)

Additionally, other funding organizations may reference PMC (or Europe PMC) as a repository available to authors for complying with an open access policy without formally partnering with NLM. In such cases, PMC will accept direct submission of all articles supported by these organizations that are published in MEDLINE journals under a selective deposit arrangement.